GlassScriptPhysician profile
David K Towns
NPI 1326116278
$1,477.80
in general payments reported to CMS, 2019-2025
14 companies · $53.12 in 2025
The $53.12 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $250 · 2021: $232 · 2022: $112 · 2023: $197 · 2024: $120 · 2025: $53.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $736.69 | 2019-2025 | Entrada, General - Pain Management |
| Abbott Laboratories | $247.36 | 2019-2023 | Proclaim |
| Lilly USA, LLC | $143.08 | 2019-2020 | |
| Saluda Medical Americas, INC. | $58.59 | 2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.29 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $48.12 | 2020-2025 | Belbuca |
| Nalu Medical, INC. | $43.06 | 2024 | Nalu Neurostimulation System |
| Takeda Pharmaceuticals U.S.A., INC. | $28.56 | 2019 | |
| Scilex Pharmaceuticals INC. | $27.91 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $25.56 | 2021 | |
| Tonix Medicines, INC. | $20.52 | 2025 | Tonmya |
| Hikma Pharmaceuticals USA | $17.61 | 2022 | |
| Alfasigma USA, INC. | $12.64 | 2021 | |
| Daiichi Sankyo INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Towns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.